Background: Treatment of Acute Lymphoblastic Leukemia (ALL) is mainly
chemotherapy based. In the past outcome of treatment with polychemotherapy was
dissatisfying. Recently success have improved as risk based polychemotherapy has
been employed. Therefore in modern approach of the treatment of ALL of children
assessment of risk factors has become a key issue. It has been observed in the
studies abroad that response to prechemotherapy corticosteroid could be a clue to
the good response to chemotherapy